| Dr Todd Aaron Meredith, MD | |
|
3028 Navarre Ave, Oregon, OH 43616-3308 | |
| (419) 697-6850 | |
| Not Available |
| Full Name | Dr Todd Aaron Meredith |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 3028 Navarre Ave, Oregon, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841283272 | NPI | - | NPPES |
| 0826388 | Medicaid | OH | |
| 26-3239286 | Other | OH | BWC |
| 35079145M | Other | OH | STATE LICENSE |
| 65124918300 | Other | OH | BWC |
| 2912415781 | Other | NRCME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 35079145M (Ohio) | Primary |
| Entity Name | Community And Rural Health Services |
|---|---|
| Entity Type | Part B Supplier - Public Health/welfare Agency |
| Entity Identifiers | NPI Number: 1780683573 PECOS PAC ID: 5395733224 Enrollment ID: O20040430001263 |
News Archive
I'm a biophysicist at the University of Bordeaux and I mainly work on bio-imaging methods in the cancer laboratory research facility, mostly for brain cancers.
Big Bend Hospice, Inc., a leading hospice agency located in Tallahassee, Fla., has chosen Allscripts Homecare software solution to improve the delivery of critical clinical information in the home, enabling the agency to focus on patient needs and better patient outcomes.
Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced financial results for the quarter ended March 31, 2013.
The study, published in the journal Phytomedicine, characterized an active compound, corilagin (a derivative from Phyllanthus urinaria), as potential SARS-CoV-2 entry inhibitors for its preventive application in daily antiviral hygiene products.
› Verified 2 days ago
| Entity Name | American Current Care Of Ohio Pa Co |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023292943 PECOS PAC ID: 0042356073 Enrollment ID: O20091006000303 |
News Archive
I'm a biophysicist at the University of Bordeaux and I mainly work on bio-imaging methods in the cancer laboratory research facility, mostly for brain cancers.
Big Bend Hospice, Inc., a leading hospice agency located in Tallahassee, Fla., has chosen Allscripts Homecare software solution to improve the delivery of critical clinical information in the home, enabling the agency to focus on patient needs and better patient outcomes.
Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced financial results for the quarter ended March 31, 2013.
The study, published in the journal Phytomedicine, characterized an active compound, corilagin (a derivative from Phyllanthus urinaria), as potential SARS-CoV-2 entry inhibitors for its preventive application in daily antiviral hygiene products.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Todd Aaron Meredith, MD 26484 Carrington Blvd, Perrysburg, OH 43551-9114 Ph: (419) 283-4497 | Dr Todd Aaron Meredith, MD 3028 Navarre Ave, Oregon, OH 43616-3308 Ph: (419) 697-6850 |
News Archive
I'm a biophysicist at the University of Bordeaux and I mainly work on bio-imaging methods in the cancer laboratory research facility, mostly for brain cancers.
Big Bend Hospice, Inc., a leading hospice agency located in Tallahassee, Fla., has chosen Allscripts Homecare software solution to improve the delivery of critical clinical information in the home, enabling the agency to focus on patient needs and better patient outcomes.
Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced financial results for the quarter ended March 31, 2013.
The study, published in the journal Phytomedicine, characterized an active compound, corilagin (a derivative from Phyllanthus urinaria), as potential SARS-CoV-2 entry inhibitors for its preventive application in daily antiviral hygiene products.
› Verified 2 days ago